Nanovibronix (NAOV)
(Delayed Data from NSDQ)
$0.76 USD
+0.01 (1.13%)
Updated Apr 26, 2024 03:49 PM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for Nanovibronix, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 2 | 1 | 2 | 1 | 1 |
Cost Of Goods | 1 | 1 | 1 | 0 | 0 |
Gross Profit | 2 | 0 | 1 | 0 | 0 |
Selling & Adminstrative & Depr. & Amort Expenses | 5 | 5 | 6 | 5 | 5 |
Income After Depreciation & Amortization | -3 | -5 | -6 | -5 | -5 |
Non-Operating Income | 0 | 0 | -9 | 1 | -1 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | -4 | -5 | -14 | -4 | -6 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -4 | -5 | -14 | -4 | -6 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -4 | -5 | -14 | -4 | -6 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -3 | -5 | -6 | -5 | -5 |
Depreciation & Amortization (Cash Flow) | 0 | 0 | 0 | 0 | 0 |
Income After Depreciation & Amortization | -3 | -5 | -6 | -5 | -5 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 1.75 | 1.42 | NA | NA | 0.35 |
Diluted EPS Before Non-Recurring Items | -2.12 | -3.84 | NA | NA | -16.60 |
Diluted Net EPS (GAAP) | -2.12 | -3.84 | -11.40 | -8.40 | -16.60 |
Fiscal Year end for Nanovibronix, Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 1.18 | 0.46 | 0.29 | 0.35 |
Cost Of Goods | NA | 0.44 | 0.11 | 0.08 | 0.12 |
Gross Profit | NA | 0.74 | 0.35 | 0.22 | 0.24 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 1.44 | 1.02 | 1.23 | 1.30 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -0.70 | -0.67 | -1.01 | -1.06 |
Non-Operating Income | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | NA | 0.10 | 0.05 | 0.05 | 0.04 |
Pretax Income | NA | -0.80 | -0.72 | -1.06 | -1.10 |
Income Taxes | NA | 0.01 | 0.00 | 0.01 | 0.00 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -0.81 | -0.73 | -1.07 | -1.10 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -0.81 | -0.73 | -1.07 | -1.10 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 2.06 | 1.72 | 1.66 | 1.65 |
Diluted EPS Before Non-Recurring Items | NA | -0.39 | -0.42 | -0.65 | -0.67 |
Diluted Net EPS (GAAP) | NA | -0.38 | -0.42 | -0.65 | -0.67 |